Dr. Carmela Abraham, Professor of Biochemistry, was awarded a $200,000 grant from the Alzheimer’s Association for her study entitled Modulators of APP Dimerization as Novel Therapeutics for Alzheimer’s Disease. The study uses an entirely innovative idea to prevent the formation of the toxic amyloid protein known to kill neurons and synapses in the brains of Alzheimer’s disease patients.
Dr. Abraham has been invited to speak at two conferences in March. In Barcelona, Spain, she will speak at the 10th International Congress on Alzheimer and Parkinson Disease on Klotho Enhancers as Novel Neuroprotective Therapeutics for Alzheimer’s Disease and White Matter Degeneration. In St. Louis, at the American Society for Neurochemistry, she will present on The Anti-Aging Protein Klotho Affects Oligodendrocyte Differentiation.